A Wearable Patch Just Beat Usual Care at Breaking the Craving-to-Use Pipeline

Craving isn’t just a mental event — it shows up in your body first, in heart rate and skin conductance, before it ever reaches the thought “I want to use.” A phase 2 randomized trial published in JAMA Psychiatry tried treating that physical signal directly: 115 adults in early recovery wore a smart patch that read their heart rate variability — the tiny beat-to-beat timing shifts that track how stressed or regulated the nervous system is — and fed it back to them in real time, coaching breathing to nudge the body out of a stress spike before the craving fully lands.

Reading a craving in the body turned out to be easier than arguing with it in the mind.

Over eight weeks, the 115 participants split into two groups: standard outpatient treatment alone, or standard treatment plus the biofeedback patch. The group without the patch got worse on both measures researchers tracked — negative mood and craving intensity both rose over the study period, the ordinary trajectory of early recovery’s hardest stretch. The group with the patch saw both drop. More specific than “cravings went down”: the biofeedback appeared to disrupt the actual mechanical link between having a craving and acting on it — participants who wore the patch were less likely to convert a craving into a drink or a dose, not just less likely to report craving in the first place.

That distinction matters for anyone who’s white-knuckled a craving and had it win anyway. Reducing craving is the harder problem; interrupting the moment where craving becomes use is the one that actually prevents relapse, and it’s the one this device targeted directly.

This is a phase 2 trial — 115 people, eight weeks, one site pool, outpatient population. It’s not yet a discharge-planning standard, and Mass General Brigham’s own researchers are explicit that it needs a larger phase 3 trial before anyone treats it as proven. But it’s a real signal that the body’s stress response, not just willpower, is a legitimate treatment target — worth a conversation with your care team about whether a wearable adjunct exists for your program, not a reason to feel like you failed if you got through early recovery without one.